title: Serum prolactin and growth hormone responses to naloxone and intracerebral ventricle morphine administration in heifers.
abstract: These studies examined responses of serum prolactin (PRL) and growth hormone (GH) to opioid agonist and antagonist administration in heifers. To minimize nonspecific and behavioral effects and to facilitate future studies with specific opioid receptor agonists, a cannula was placed within the third cerebral ventricle of the brain of 4- to 10-mo-old heifers to directly access hypothalamic regions involved in the regulation of PRL and GH secretion. Increasing doses of morphine (M) from 2 to 1,500 micrograms injected into the third cerebral ventricle increased (P less than .001) serum PRL concentrations in a dose-related manner. Growth hormone responses were variable, resulting in elevated (P less than .05) serum concentrations following morphine, but no dose-related effects were apparent. Both PRL and GH responses to 700 micrograms M were absent when an intracerebral ventricle injection of an equimolar dose of naloxone, an opioid receptor antagonist, was administered prior to M. In a replicated 4 x 4 latin square, the effects of intravenous naloxone on PRL and GH responses was tested in young (86 +/- 11 d) and older (234 +/- 6 d) heifers. Naloxone at doses of 1, 2 and 4 mg/kg reduced (P less than .05) serum concentrations of PRL for 45 to 60 min. Mean concentrations of GH tended to be higher (P less than .07) in older heifers All doses of naloxone decreased (P less than .05) serum GH concentrations in older heifers but proved ineffective in younger heifers. There were no differences between doses of naloxone on either PRL or GH. These data suggest that endogenous opioids are involved in the regulation of PRL and GH secretion in heifers.
authors.affiliation: University of Georgia, Athens 30602.
authors.forename: L S
authors.initials: LS
authors.lastname: Leshin
authors.forename: L A
authors.initials: LA
authors.lastname: Rund
authors.forename: F N
authors.initials: FN
authors.lastname: Thompson
authors.forename: M B
authors.initials: MB
authors.lastname: Mahaffey
authors.forename: W J
authors.initials: WJ
authors.lastname: Chang
authors.forename: D J
authors.initials: DJ
authors.lastname: Byerley
authors.forename: T E
authors.initials: TE
authors.lastname: Kiser
mesh_terms: D000818:Animals; D002417:Cattle / Q000097:blood / Q000378:metabolism*; D004305:Dose-Response Relationship, Drug; D005260:Female; D013006:Growth Hormone / Q000097:blood* / Q000378:metabolism; D007031:Hypothalamus / Q000187:drug effects / Q000378:metabolism; D007276:Injections, Intraventricular / Q000662:veterinary; D009020:Morphine / Q000008:administration & dosage / Q000494:pharmacology*; D009270:Naloxone / Q000494:pharmacology*; D011388:Prolactin / Q000097:blood* / Q000378:metabolism
chemical_list: D009270:Naloxone; D009020:Morphine; D011388:Prolactin; D013006:Growth Hormone